Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01747928 · ClinicalTrials.gov registry record · Early Phase 1
Users Study Of The Caverject Delivery System
A Early Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 48
- Enrollment target
NCT01747928 is a Early Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 48 participants.
The verdict
NCT01747928, a Early Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 48 participants
- Enrollment target
Study Summary
Usability testing of the dual-chambered syringe in conjunction with the proposed patient instructions for use.
Interventions
- OTHER dual-chamber syringe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2013-03 |
| Est. Completion | 2013-03 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01747928
The ClinicalTrials.gov registry entry for NCT01747928 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which dual-chamber syringe is the first listed.
NCT01747928 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01747928 about?
NCT01747928 is a clinical study titled "Users Study Of The Caverject Delivery System". Usability testing of the dual-chambered syringe in conjunction with the proposed patient instructions for use.
What is the current status of trial NCT01747928?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 48 participants. The study started on 2013-03. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01747928?
The interventions under investigation include: dual-chamber syringe (OTHER).
Who is sponsoring clinical trial NCT01747928?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.